In rats with high-fat-diet-induced NASH, celecoxib, a selective COX2 inhibitor, significantly reduces hepatic lipid accumulation and improves insulin resistance (Tian et al., 2014). The gene discussed is PTGS2; the disease is Insulin resistance.